2026年11月3日星期二
M
Küresel Panorama
Küresel haberler
Working collaboratively to fight scams in Asia Pacific— Google 官方博客Camarines Norte communities take charge of local climate fight— Rappler 菲律宾拉普勒St. Luke’s, NPC investigating data breach on mobile app— Rappler 菲律宾拉普勒Merz says next German president should be a woman— The Local Germany 德国本地Anthropic seeks to raise up to $3.5bn from Japanese investors in IPO— 日经 Nikkei AsiaJapan can build defense edge on AI, Palantir CEO says— 日经 Nikkei AsiaEU steps up subsea cable buildout to Japan and South Korea— 日经 Nikkei AsiaJapan's Don Quijote drops refund fees for tourists to boost spending— 日经 Nikkei AsiaWorking collaboratively to fight scams in Asia Pacific— Google 官方博客Camarines Norte communities take charge of local climate fight— Rappler 菲律宾拉普勒St. Luke’s, NPC investigating data breach on mobile app— Rappler 菲律宾拉普勒Merz says next German president should be a woman— The Local Germany 德国本地Anthropic seeks to raise up to $3.5bn from Japanese investors in IPO— 日经 Nikkei AsiaJapan can build defense edge on AI, Palantir CEO says— 日经 Nikkei AsiaEU steps up subsea cable buildout to Japan and South Korea— 日经 Nikkei AsiaJapan's Don Quijote drops refund fees for tourists to boost spending— 日经 Nikkei Asia

Fresenius Taps China’s WuXi to Expand Biosimilar Drug Portfolio

Kaynak Bloomberg 财经22 saat önce
İçerik özeti

Fresenius SE agreed to partner with Chinese contract drug developer WuXi Biologics on biosimilar candidates that could reach the market in the next decade, pot…

Bu site yalnızca başlık ve özet dizini sunar; tam içerik ve telif hakkı asıl yayıncıya aittir, lütfen okumak için orijinal bağlantıya tıklayın.

Orijinal metne git
Ait olduğu kanal
Finans
Ait olduğu bölge
Amerika
Orijinal dil
English
Kayıt numarası
business-d4188171

Comments 0 comments

No comments yet. Be the first.

Fresenius Taps China’s WuXi to Expand Biosimilar Drug Portfolio · Küresel Panorama